Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease [6]

Gut

Volumn 55, Issue 5, 2006, Pages 746-

  Joossens, S ^a   Pierik, M ^a   Rector, A ^b   Vermeire, S ^a   Ranst, M V ^b   Rutgeerts, P ^a   Bossuyt, X ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN BINDING LECTIN;

CROHN DISEASE; DNA POLYMORPHISM; EXON; LETTER; MEDICAL RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ANTIBODIES, FUNGAL; CROHN DISEASE; HUMANS; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; SACCHAROMYCES CEREVISIAE;

EID: 33646258044     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.089136     Document Type: Letter

References (2)

1. Seibold F, Konrad A, Flogerzi B, et al. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 2004;127:1076-84.
2. Rector A, Lemey P, Laffut W, et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease. Genes Immun 2001;2:323-8.